<DOC>
	<DOCNO>NCT01003171</DOCNO>
	<brief_summary>This study examine pharmacokinetics , absorption serum concentration MCS component once-daily oral dose MCS .</brief_summary>
	<brief_title>Pharmacokinetics MCS Healthy Volunteers</brief_title>
	<detailed_description>This study open-label , multiple-dose study , whose objective examine pharmacokinetics MCS component once-daily oral dose 21 day . Subjects undergo 14-day washout phase enter 21-day treatment phase . During treatment phase , subject receive MCS , once-daily within one hour even meal . After completion treatment phase , subject enter post-treatment 42-day washout phase . Throughout phase , blood sample collect assayed concentration MCS component . The duration protocol participation expect 77 day eligible subject completes study .</detailed_description>
	<criteria>Normal healthy volunteer 18 year age old Subjects comply study procedure sign inform consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>PK</keyword>
	<keyword>MCS</keyword>
	<keyword>Benign Prostatic Hyperplasia</keyword>
	<keyword>Multi-Carotenoids</keyword>
	<keyword>Healthy subject</keyword>
</DOC>